1. Home
  2. Live Updates
  3. Ret mutation

Live Breaking News & Updates on Ret Mutation

Stay updated with breaking news from Ret mutation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

COMING SOON: Randomized Phase 3 Study of First-Line Selpercatinib Versus Pembrolizumab and Chemotherapy in RET Fusion-Positive Non-Small Cell Lung Cancer

Expert oncologist Benjamin P. Levy, MD, shares his excitement for an upcoming program centered on recent data with selpercatinib versus pembrolizumab in patients with non-small cell lung cancer following ESMO 2023. ....

Randomized Phase , First Line Selpercatinib Versus Pembrolizumab , Positive Non Small Cell Lung Cancer , Non Small Cell Lung Cancer , Lung Cancer , Ret Fusion , Ret Mutation , Ret Positive , Chemo Io , Loxo 292 , Esmo 2023 , Esmo Annual Meeting , Novel Therapy , Targeted Therapy ,